Silent adrenal pheochromocytoma coexistent with corticomedullary hyperplasia: a case incidentally discovered by Luigi, Petramala et al.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000714 European Journal of Case Reports in Internal Medicine © EFIM 2017
Doi: 10.12890/2017_000714 - European Journal of Case Reports in Internal Medicine - © EFIM 2017
Silent Adrenal Pheochromocytoma Coexistent with Corticomedullary 
Hyperplasia: A Case Incidentally Discovered
Luigi Petramala1, Antonio Concistrè1, Federica Olmati1, Vincenza Saraceno1, Gino Iannucci1, 
Antonio Ciardi2, Giorgio De Toma2, Claudio Letizia1
1Specialized Center of Secondary Hypertension, Department of Internal Medicine and Medical Specialties, University “Sapienza”, Rome, Italy 
2Department of Surgery “Pietro Valdoni”, University “Sapienza”, Rome, Italy
Received: 27/07/2017
Accepted: 04/08/2017
Published: 06/10/2017
How to cite this article: Petramala L, Concistrè A, Olmati F, Saraceno V, Iannucci G, Ciardi A, De Toma G, Letizia C. Silent adrenal pheochromocytoma 
coexistent with corticomedullary hyperplasi: a case incidentally discovered. EJCRIM 2017;4: doi:10.12890/2017_000714.
Conflicts of Interests: The Authors declare that there are no competing interests.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License
ABSTRACT
Introduction: Pheochromocytoma (PHEO) is a rare catecholamine-producing tumour arising from chromaffin cells in the sympatho-adrenal 
system, and can present as asymptomatic adrenal incidentaloma (AI).
Patient: We describe the case of a 61-year-old woman with a right adrenal mass incidentally discovered, who was biochemically characterized 
with subclinical hypercortisolism (SH). The patient was scheduled for adrenalectomy because of increasing seizure of the right adrenal 
gland with a haemorrhagic and focal pseudocystic appearance macroscopically, incidental histological and immunohistochemical PHEO, and 
micronodular cortico-adrenal hyperplasia.
Discussion: This report describes a rare case of incidental non-functioning PHEO coexisting with corticomedullary hyperplasia and SH. 
LEARNING POINTS
•  Rare presentation of coexisting common (adrenal incidentaloma and subclinical Cushing’s syndrome) and uncommon (pheochromocytoma) 
endocrinological conditions.
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INTRODUCTION 
Pheochromocytoma (PHEO) is a rare catecholamine-producing tumour arising from chromaffin cells in the sympatho-adrenal system, and 
has a prevalence of 0.1–0.6%[1]. Hypertension, either paroxysmal or sustained, is the most consistent finding in PHEO, and the classic triad of 
symptoms (headache, palpitations and diaphoresis) is present in more than 50% of patients[2]. However, PHEO can present as asymptomatic 
adrenal incidentaloma (AI) revealed during abdominal imaging.
CASE REPORT
In May 2016, a 61-year-old woman was referred to our centre for evaluation of a right adrenal mass (diameter 44 mm) and arterial 
hypertension. She did not complain of any relevant symptoms. In July 2010, the patient had been evaluated in another hospital with an 
incidental finding of a right adrenal mass (diameter 28 mm) (Fig. 1), with biochemical and hormonal corticomedullary findings in the normal 
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range (Table 1). The patient was treated with ramipril (10 mg/day) and amlodipine (10 mg/day).
On physical examination, the patient’s heart rate was 61 bpm and her blood pressure (BP) was 150/90 mmHg without postural drop, her 
BMI was 30.7 kg/m2, and she had a waist circumference of 107 cm. No signs of hypercortisolism, such as buffalo hump, moon face, striae or 
skin abnormalities, were seen. Ambulatory blood pressure monitoring (ABPM) revealed a global mean BP of 135/85 mmHg without a drop 
in nocturnal BP (non-dipping profile). The EKG was unremarkable. Routine blood tests were normal. Hormonal evaluation was performed 
after adequate preparation (Table 1). In particular, urinary free cortisol (UFC) and plasma cortisol (PC) following an overnight dexamethasone 
test were high and associated with a low plasma ACTH value. A diagnosis of subclinical hypercortisolism (SH) was made, and considering 
the increasing diameter of the adrenal mass, the patient underwent a laparoscopic adrenalectomy. Intraoperatively, the patient did not 
experience any haemodynamic alterations. The post-operative course was uneventful, and the patient was discharged from hospital on a 
cortisol substitute and attended regular follow-up appointments. 
Figure 1. Computed tomography of the abdomen showing an incidental finding 
of a right adrenal mass (diameter 28 mm)
July 2010 May 2016 December 2016 Normal Values
Serum
Plasma aldosterone (pg/ml) 128 106 86 30-160
Plasma cortisol (mg/dl) 11 15.6 14.7 6-23
Plasma renin activity (ng/ml/h) 3 0.4 1.2 0.5-3
ACTH (pg/ml) 19 7 22 8-50
Plasma cortisol after 1 mg of 
dexamethasone (overnight test) - 3.5 - <1.8
Urine
Urinary free cortisol (mg/24 h) 160 256.8 198.2 38–208
Urinary mandelic acid (mg/24 h) 5 6.6 5.3 0-10.6
Urinary total catecholamine (mg/24 h) 70 – – –
Urinary aldosterone secretion 
(mg/24 h)
– 13.9 8.6 2.84–34
Urinary total metanephrines (mg/24 h) – 264 55 20–350
Table 1. Endocrinological data of the patient 6 years before diagnosis, at diagnosis and 6 months after laparoscopic removal of the tumour
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000714 European Journal of Case Reports in Internal Medicine © EFIM 2017
PATHOLOGICAL EXAMINATIONS
Macroscopically, the right adrenal gland measured 6×4×3.2 cm and was a rusty-coloured nodule with a haemorrhagic and focal pseudocystic 
appearance. The remnant adrenal gland had a cortex with a micronodular pattern around a widened greyish medulla. Histology revealed 
a lesion with tumour cells arranged in well-defined nests. The nuclei were round or oval with prominent nucleoli, occasionally containing 
inclusion-like striatures (cytoplasmic invaginations). The mitotic rate was 3/10 HPF (Fig. 2). No necrosis or vascular invasion was recorded. A 
multinodular pattern was observed in the residual cortex, with an obvious zona fasciculata. The medulla of the normal gland showed widening 
(cortex/medulla ratio <10:1), with cells arranged in a nest. Immunohistochemistry using antibody against chromogranin, synaptophysin and 
neuron-specific enolase showed positive results, but anti-inhibin was negative. S-100 protein immunoreactivity showed a conspicuous 
number of substentacular cells. Immunohistochemical studies using antibody against ACTH were positive in the adrenal cortex and medulla 
(Fig. 3). A final diagnosis was made of adrenal PHEO accompanied by micronodular cortico-medullary hyperplasia. The patient was examined 
6 and 12 months post-operatively and showed normal adrenal hormone values (Table 1). No further cortisol treatment was given.
Figure 2. Histological results for the adrenal cortex showing a multinodular 
pattern in the zona fasciculata <p
DISCUSSION
This report describes a rare case of incidental non-functioning PHEO coexisting with corticomedullary hyperplasia and SH. Approximately 
5–6.5% of AI are PHEO, and a few rare patients with PHEO are completely asymptomatic[1, 2]. In our patient, none of the specific signs and 
symptoms of hyperproduction of catecholamines were present at diagnosis. The clinical and biohumoral presentation of PHEO depends on 
the ability of the neoplasm to synthetize, metabolize and release different catecholamines and their metabolites. A tumour predominantly 
secreting epinephrine is usually associated with paroxysmal hypertension, while the norepinephrine variant is associated with sustained 
hypertension[3]. The lack of classic features of PHEO in our patient can be explained by the repeated normal urinary metanephrines. 
Hormonal evaluation revealed autonomous glucocorticoid production without specific signs and symptoms of hypercortisolism[4]. 
Histopathological examination of the adrenal mass revealed PHEO associated with corticomedullary hyperplasia.
The results of this study suggest that the adrenal medulla is not only influenced by the cortex but also influences the cortex directly or 
through the systemic circulation[5]. In particular, we hypothesize that the presence of immunoreactive ACTH in PHEO may be a possible 
cause of adrenocortical hyperplasia. 
In conclusion, we present a rare case of silent adrenal PHEO incidentally discovered and associated with SH with corticomedullary 
hyperplasia.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000714 European Journal of Case Reports in Internal Medicine © EFIM 2017
REFERENCES
1. Tischler AS, Pacak K, Eisenhofer G. The adrenal medulla and extra-adrenal paraganglia: then and now. Endocr Pathol 2014;25:49–58. 
2. Cotesta D, Petramala L, Serra V, Pergolini M, Crescenzi E, Zinnamosca L, et al. Clinical experience with pheochromocytoma in a single centre over 16 years. High Blood Press 
Cardiovasc Prev 2009;16:183–193.
3. Mannelli M, Lenders JW, Pacak K, Parenti G, Eisenhofer G. Subclinical phaeochromocytoma. Best Pract Res Clin Endocrinol Metab 2012;26:507–515.
4. Petramala L, Cavallaro G, Galassi M, Marinelli C, Tonnarini G, Concistrè A, et al. Clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism due 
to adrenal incidentaloma: results from a single center. High Blood Press Cardiovasc Prev 2017;24:69–75.
5. Lefebvre H, Thomas M, Duparc C, Bertherat J, Louiset E. Role of ACTH in the interactive/paracrine regulation of adrenal steroid secretion in physiological and pathophysiological 
conditions. Front Endocrinol (Lausanne) 2016;7:98.
